People's United Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$546K Sell
3,167
-367
-10% -$61.8K 0.02% 441
2021
Q4
$898K Buy
3,534
+1,215
+52% +$355K 0.02% 379
2021
Q3
$892K Buy
2,319
+195
+9% +$71.9K 0.02% 401
2021
Q2
$499K Buy
2,124
+120
+6% +$21.4K 0.01% 512
2021
Q1
$262K Buy
+2,004
New +$290K 0.01% 619

Other funds holding MRNA

People's United Financial's MRNA Position: Q1 2022 in Review

People's United Financial reduced its Moderna (MRNA) stake by 10% in Q1 2022, selling an estimated $61.8K and leaving 3,167 shares worth $546K. The position accounts for 0.02% of the portfolio, ranked #441.

People's United Financial first reported a position in MRNA in Q1 2021 and has held it in 5 quarters since. The position peaked at $898K in Q4 2021. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • People's United Financial held 3,167 shares of Moderna worth $546K as of Q1 2022.
  • People's United Financial sold 367 Moderna shares in Q1 2022, an estimated $61.8K.
  • Moderna made up 0.02% of People's United Financial's portfolio in Q1 2022, its #441 holding.
  • People's United Financial first reported a position in Moderna in Q1 2021 and has held it in 5 quarters since.
  • People's United Financial's Moderna position peaked at $898K in Q4 2021.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.